Background Variants of the apolipoprotein E allele appear to account for most cases of late-onset
Alzheimer's disease, and persons with two copies of the ε4 allele appear to have an …

Vascular contributions to dementia and Alzheimer’s disease are increasingly recognized 1 ,
2 , 3 , 4 , 5 – 6 . Recent studies have suggested that breakdown of the blood–brain barrier (…

Fluorodeoxyglucose positron emission tomography (PET) studies have found that patients
with Alzheimer's dementia (AD) have abnormally low rates of cerebral glucose metabolism in …

Fibrillar amyloid-beta (Aβ) is found in the brains of many cognitively normal older people.
Whether or not this reflects a predisposition to Alzheimer's disease (AD) is unknown. We used …

Background The APOE ε4 allele is associated with the risk of late-onset Alzheimer's disease.
The age at which memory decline diverges among persons who are homozygous for the …

The TAR DNA-binding protein 43 (TDP-43) has been identified as the major disease protein
in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin …

The apolipoprotein E (APOE) ɛ4 allele is the best established genetic risk factor for late-onset
Alzheimer's disease (LOAD). We conducted genome-wide surveys of 502,627 single-…

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are age-related
neurodegenerative disorders with shared genetic etiologies and overlapping clinical and …

Cross-sectional positron emission tomography (PET) studies find that cognitively normal
carriers of the apolipoprotein E (APOE) ɛ4 allele, a common Alzheimer's susceptibility gene, …

Human memory is a polygenic trait. We performed a genome-wide screen to identify
memory-related gene variants. A genomic locus encoding the brain protein KIBRA was significantly …